Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis

NCT00726804 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped It was not possible to recruit patients

Conditions

SPONDYLOARTHRITIS

Interventions

DRUG: Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab)

Sponsor

Glostrup University Hospital, Copenhagen